In this special bonus episode of OvaryActive, Dr. Rebecca Dunsmoor-Su and Dr. Amy Voedisch celebrate the arrival of their new book, Estrogen, Interrupted and share an excerpt from the audiobook.

This preview introduces their candid, science-backed approach to perimenopause: the symptoms no one warned you about, why "it's normal" is not a treatment plan, and why women deserve better information, better care, and a lot less medical shrugging.

Listen in for a first taste of the book, including what perimenopause really is, why it can feel so unpredictable, and how Rebecca and Amy are working to make this stage of life less confusing, less isolating, and slightly less "why are my pants suddenly attacking me?

Links:

Get your copy of Estrogen, Interrupted: bit.ly/Estrogen-Interrupted-preorder

Follow the show @OvaryActive Instagram | YouTube | perimenopausedrs.com/ovaryactive

Estrogen, Interrupted by Dr. Rebecca Dunsmoor-Su & Dr. Amy Voedisch

This episode was produced by Audiotocracy Podcast Production.

Perimenopause is already handing out enough surprises without the internet yelling that menopausal hormone therapy is either a miracle cardiology cape or a one-way ticket to doom.

In this episode of OvaryActive, Dr. Rebecca Dunsmoor-Su and Dr. Amy Voedisch take on the very confusing question of whether hormone therapy can help prevent cardiovascular disease in menopause.

They walk through the history of hormone therapy and heart health, from large observational studies like Framingham and the Nurses' Health Study to the much-debated Women's Health Initiative, a study that launched roughly a thousand menopause panic spirals.

The doctors explain why timing matters, why older hormone therapy data does not always apply to today's estradiol options, and why oral versus transdermal estrogen is more nuanced than "patch good, pill bad."

So yes, hormones can be fabulous. But no, they do not replace exercise, lipid screening, diabetes care, statins when needed, or the deeply annoying truth that lifestyle still matters.

What you'll hear in this episode:

[2:45] Where the "estrogen protects the heart" idea came from

[5:02] The Women's Health Initiative and why timing matters

[6:31] Plaque, blood clots, and starting hormones later

[7:26] The timing hypothesis and "window of opportunity"

[7:59 Older hormone therapy studies don't always match current treatments…why?

[12:04] What we know about oral estradiol, transdermal estrogen, and the liver

[16:40] Medicare data, mortality claims, and why database studies are tricky

[18:37] Can MHT prevent cardiovascular disease?

[20:37] Proven heart-health strategies that matter most

[22:42] What hormones can help with, and what they CAN'T promise

Follow the show @OvaryActive Instagram | YouTube | perimenopausedrs.com/ovaryactive

Estrogen, Interrupted by Dr. Rebecca Dunsmoor-Su & Dr. Amy Voedisch

Meet the Docs:

More information about Dr. Rebecca Dunsmoor-Su:

Gennev: www.gennev.com/clinician/dr-rebecca-dunsmoor-su

LinkedIn @rebecca-dunsmoor-su

More information about Dr. Amy Voedisch:

Stanford Medical Clinic: stanfordhealthcare.org/doctors/v/amy-voedisch.html

This episode was produced by Audiotocracy Podcast Production.

Perimenopause is apparently the perfect time to start worrying about dementia, cholesterol, hearing aids, and whether your brain is quietly packing its bags.

This episode of OvaryActive is part 2 of the conversation with Dr. Ayesha Sherzai of the Brain Docs. Dr. Rebecca Dunsmoor-Su and Dr. Amy Voedisch are talking with Dr. Sherzai all about dementia prevention, brain health, and the deeply rude realization that the "boring stuff" might actually matter.

This episode picks up with the Lancet Dementia Commission report and the 14 modifiable risk factors linked to dementia, including hearing loss, high LDL cholesterol, depression, diabetes, smoking, physical inactivity, hypertension, obesity, social isolation, vision loss, and more.

Dr. Sherzai explains why midlife is such an important window for prevention, how hearing aids are no longer giant beige Lego pieces, and why statins deserve a much better PR team.

Listeners will learn what really helps reduce dementia risk, what to know about APOE4 genetic testing, and why menopausal hormone therapy should not be started for dementia prevention alone. The conversation also goes over brain health supplements, the limits of "natural" wellness claims, and why expensive pee is not a long-term cognitive strategy.

What you'll hear in this episode:

[0:53] Lancet Report explained

[5:50] 14 risk factors

[7:57] Midlife window shift

[9:15] Hearing loss breakthrough

[14:18] Reading and APOE

[16:57] APOE and LDL

[21:30] Statins for prevention

[24:30] Hormones and dementia

[29:52] Social media hype

[32:52] Supplements reality check

Links:

thebraindocs.com

Find the Brain Docs on Instagram: @thebraindocs

Find the Brain Docs on Facebook: @BrainDocsFB

Find the Brain Docs on YouTube: @theBrainDocs

Purchase The NEURO Plan Playbook: thebraindocs.com/playbook

Follow the show @OvaryActive Instagram | YouTube | perimenopausedrs.com/ovaryactive

Estrogen, Interrupted by Dr. Rebecca Dunsmoor-Su & Dr. Amy Voedisch

Meet the Docs:

More information about Dr. Rebecca Dunsmoor-Su:

Gennev: www.gennev.com/clinician/dr-rebecca-dunsmoor-su

LinkedIn @rebecca-dunsmoor-su

More information about Dr. Amy Voedisch: Stanford Medical Clinic: stanfordhealthcare.org/doctors/v/amy-voedisch.html

This episode was produced by Audiotocracy Podcast Production.